Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL1919045

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition cSRC expressed in Sf9 cells after 60 mins by TR-FRET Assay
2
Total Activities
2
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Cell Type Sf9
Confidence 8 — Homologous single protein target
Curated By Autocuration

Target

Proto-oncogene tyrosine-protein kinase Src (CHEMBL267)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis.
Kim KH, Maderna A, Schnute ME, Hegen M, Mohan S, Miyashiro J, Lin L, Li E, Keegan S, Lussier J, Wrocklage C, Nickerson-Nutter CL, Wittwer AJ, Soutter H, Caspers N, Han S, Kurumbail R, Dunussi-Joannopoulos K, Douhan J, Wissner A.
Bioorg Med Chem Lett (2011) 21 : 6258 -6263
PubMed 21958547 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 2 6.16 6.53

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL1916891 1 6.53
CHEMBL1916897 1 5.79

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL1916891 IC50 = 298.0 nM 6.53
CHEMBL1916897 IC50 = 1620.0 nM 5.79